viewGalliford Try Holdings Plc

Galliford Try shares crumble on huge profit warning

The housebuilder is writing down the value of some of its big construction contracts, including the Queensferry Crossing, which has run well over budget

queensferry crossing
Galliford is guiding for an adjusted pre-tax profit of between £116-126mln this year

Galliford Try PLC (LON:GFRD) shares crumbled on Tuesday as the housebuilder warned a writedown of various contracts in its construction business will dent annual profits by up to £40mln.

The massive profit warning sent shares down by 16.6% in early deals to 604.8p, taking Galliford to the bottom of the FTSE 250.

READ: Crest Nicholson nabs Galliford Try boss

The housebuilder is to undertake a strategic review of its construction business which would see it ‘reassess’ some of its current contracts, notably the £1.3bn Queensferry Crossing in Scotland, which is running well over budget.

There was no change to the 58km-long link road it recently finished in Aberdeen, on which it booked a £26mln loss in the first-half of its financial year.

“The board expects that the outcome of this assessment will reduce the group's full year post-exceptional profit before tax by £30-£40mln below the current consensus analysts' forecast,” read Tuesday’s statement.

Ex-CEO left at end of March

According to company data, analysts had been expecting an adjusted pre-tax profit of around £156mln this year.

The decision to write down contracts and cut guidance comes just a few weeks after former chief executive Peter Truscott left for rival Crest Nicholson PLC (LON:CRST) and was replaced by finance boss Graham Prothero.

The conclusions of the review are expected to be finalised within the next few weeks, and an update will be included in a trading update next month.

Analysts thought crossing has been completed

“Galliford Try has announced that it is undertaking a strategic view of construction, most likely as new CEO Graham Prothero takes his position,” said City broker Liberum in a note to clients.

“The upshot is that construction will likely to become smaller in future, which is positive, but that this comes at an exceptional cost of £30-40mln (c27-36p per share).

This exceptional should be a genuine one-off [as it] mainly relates to the Queensferry Crossing, which we thought had been completed.

“The statement says that guidance for June 2019 average net debt is unchanged, which means there was contingency built into that.

“Shares look very cheap even before any fall, on a 25% discount to our target of 970p.”

Quick facts: Galliford Try Holdings Plc

Price: 128 GBX

Market: AIM
Market Cap: £142.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Orthocell's Paul Anderson hails FDA approval for dental bone and tissue...

Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....

2 days, 18 hours ago

2 min read